Wird geladen...

Kinase-Independent Mechanisms of Resistance of Leukemia Stem Cells to Tyrosine Kinase Inhibitors

Tyrosine kinase inhibitors such as imatinib mesylate have changed the clinical course of chronic myeloid leukemia; however, the observation that these inhibitors do not target the leukemia stem cell implies that patients need to maintain lifelong therapy. The mechanism of this phenomenon is unclear:...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Ichim, Christine Victoria
Format: Artigo
Sprache:Inglês
Veröffentlicht: AlphaMed Press 2014
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3973707/
https://ncbi.nlm.nih.gov/pubmed/24598782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5966/sctm.2012-0159
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!